ETANERCEPT

Course overview

ETANERCEPT IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF AUTOIMMUNE CONDITIONS SUCH AS PLAQUE PSORIASIS, RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, JUVENILE IDIOPATHIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS. IT IS A BIOLOGIC FUSION PROTEIN IN THE TNF BLOCKER CLASS OF MEDICATIONS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR ETANERCEPT AS A VALUABLE AGENT IN THE MANAGEMENT OF THESE DISEASES AND OTHER DISORDERS WHEN APPLICABLE. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF PATIENTS WITH PSORIASIS, AUTOIMMUNE ARTHRITIS, AND RELATED CONDITIONS.